Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

Ebru Yılmaz; Özge Pasin; Loiane Cristina de Souza; Guilherme Torres Vilarino; Alexandro Andrade; Camila Gusmão Vicente de Carvalho; Barbara Bayeh; Fernando Henrique Carlos de Souza; Renata Miossi; Pleiades Tiharu Inaoka; Takashi Matsushita; Naoki Mugii; Samuel Katsuyuki Shinjo

doi:10.4081/reumatismo.2024.1709

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents

S.L. Bello, L. Serafino, C. Bonali, N. Terlizzi, C. Fanizza, C. Anecchino, G. Lapaldula

299-306

11-12-2012

https://doi.org/10.4081/reumatismo.2012.299

2262

PDF: 1206
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2631

PDF: 1360
IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

S. Iervolino, M. Lofrano, M.N.D. Di Minno, F. Foglia, R. Scarpa, R. Peluso

40-43

19-03-2012

https://doi.org/10.4081/reumatismo.2012.40

957

PDF: 1525
Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

J. Mencarini, M. Spinicci, F. Bartalesi

144-147

16-12-2016

https://doi.org/10.4081/reumatismo.2016.897

1845

PDF: 1111
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

83-89

09-09-2016

https://doi.org/10.4081/reumatismo.2016.875

1839

PDF: 898

IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 518
GISEA: an Italian biological agents registry in rheumatology

G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

155-164

09-11-2011

https://doi.org/10.4081/reumatismo.2011.155

2295

PDF: 1545
Are biological drugs safe in pregnancy?

A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

304-317

31-03-2015

https://doi.org/10.4081/reumatismo.2014.798

3719

PDF: 2397
Pain in rheumatic diseases: how relevant is it?

P. Sarzi-Puttini, F. Atzeni, F. Salaffi

1-3

06-06-2014

https://doi.org/10.4081/reumatismo.2014.757

1991

PDF: 1141
The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia

188-194

31-12-2016

https://doi.org/10.4081/reumatismo.2016.903

1743

PDF: 917
Management of cutaneous discomfort in patients with scleroderma: a clinical trial

M. Muratore, L. Quarta, L. Raho, D. Costanza, S. Frisenda, F. Calcagnile, A. Grimaldi, E. Quarta, D. Carati, M. Guido, A. Zizza, G. Alessandrini

240-247

18-12-2013

https://doi.org/10.4081/reumatismo.2013.240

3294

PDF: 1038
A short history of anti-rheumatic therapy - VII. Biological agents

G. Pasero, P. Marson, B. Gatto

185-194

09-11-2011

https://doi.org/10.4081/reumatismo.2011.185

1485

PDF: 1219
Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

31-38

https://doi.org/10.4081/reumatismo.2006.31

1777

PDF: 2516
Successful treatment of refractory adult onset Still’s disease with rituximab

N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman

159-162

16-12-2016

https://doi.org/10.4081/reumatismo.2016.888

2415

PDF: 1177
Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali

17-07-2023

https://doi.org/10.4081/reumatismo.2023.1544

999

PDF: 541
A short history of anti-rheumatic therapy. II. Aspirin

G. Pasero, P. Marson

148-156

https://doi.org/10.4081/reumatismo.2010.148

2425

PDF: 1483
Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

41-49

https://doi.org/10.4081/reumatismo.2008.41

1154

PDF: 773
CONVENTIONAL THERAPY OF PSORIATIC ARTHRITIS: EVIDENCE-BASED REVIEW

N.J. Mchugh, E.R. Soriano

81-84

https://doi.org/10.4081/reumatismo.2007.1s.81

757

PDF: 752
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

19-12-2023

https://doi.org/10.4081/reumatismo.2023.1602

1784

PDF: 429
Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

S. Zingarelli, P. Airò, M. Frassi, C. Bazzani, M. Scarsi, M. Puoti

22-27

https://doi.org/10.4081/reumatismo.2008.22

1154

PDF: 945
On the main stages of the history of intra-articular therapy

P. Marson, G. Pasero, L. Punzi, G. Zanchin

262-268

https://doi.org/10.4081/reumatismo.2007.262

1352

PDF: 1114
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino

07-02-2022

https://doi.org/10.4081/reumatismo.2021.1470

9288

PDF: 2042
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

27-01-2025

https://doi.org/10.4081/reumatismo.2025.1694

1476

PDF: 15
Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

G. Ferraccioli

46-50

https://doi.org/10.4081/reumatismo.2004.1s.46

686

PDF: 673
Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

244-261

https://doi.org/10.4081/reumatismo.2007.244

1287

PDF: 1104
Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

224-235

https://doi.org/10.4081/reumatismo.2003.224

1105

PDF: 2504
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

173-177

19-11-2020

https://doi.org/10.4081/reumatismo.2020.1289

1604

PDF: 993
Safety of anti-TNFa biological drugs

F. Trotta, G. Valentini

34-39

https://doi.org/10.4081/reumatismo.2005.4s.34

1128

PDF: 1121
Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti

24-06-2024

https://doi.org/10.4081/reumatismo.2024.1608

1458

PDF: 531

1 - 28 of 28 items

Search

Search Results

Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report

Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

GISEA: an Italian biological agents registry in rheumatology

Are biological drugs safe in pregnancy?

Pain in rheumatic diseases: how relevant is it?

The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

Management of cutaneous discomfort in patients with scleroderma: a clinical trial

A short history of anti-rheumatic therapy - VII. Biological agents

Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

Successful treatment of refractory adult onset Still’s disease with rituximab

Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients

A short history of anti-rheumatic therapy. II. Aspirin

Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

CONVENTIONAL THERAPY OF PSORIATIC ARTHRITIS: EVIDENCE-BASED REVIEW

Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

On the main stages of the history of intra-articular therapy

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Safety of anti-TNFa biological drugs

Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

authors

reviewers

Categories

indexing

Keywords